Literature DB >> 26462502

Multivariate Genetic Correlates of the Auditory Paired Stimuli-Based P2 Event-Related Potential in the Psychosis Dimension From the BSNIP Study.

Mohammadreza Mokhtari1, Balaji Narayanan2, Jordan P Hamm3, Pauline Soh1, Vince D Calhoun4, Gualberto Ruaño5, Mohan Kocherla5, Andreas Windemuth6, Brett A Clementz3, Carol A Tamminga7, John A Sweeney7, Matcheri S Keshavan8, Godfrey D Pearlson9.   

Abstract

OBJECTIVE: The complex molecular etiology of psychosis in schizophrenia (SZ) and psychotic bipolar disorder (PBP) is not well defined, presumably due to their multifactorial genetic architecture. Neurobiological correlates of psychosis can be identified through genetic associations of intermediate phenotypes such as event-related potential (ERP) from auditory paired stimulus processing (APSP). Various ERP components of APSP are heritable and aberrant in SZ, PBP and their relatives, but their multivariate genetic factors are less explored.
METHODS: We investigated the multivariate polygenic association of ERP from 64-sensor auditory paired stimulus data in 149 SZ, 209 PBP probands, and 99 healthy individuals from the multisite Bipolar-Schizophrenia Network on Intermediate Phenotypes study. Multivariate association of 64-channel APSP waveforms with a subset of 16 999 single nucleotide polymorphisms (SNPs) (reduced from 1 million SNP array) was examined using parallel independent component analysis (Para-ICA). Biological pathways associated with the genes were assessed using enrichment-based analysis tools.
RESULTS: Para-ICA identified 2 ERP components, of which one was significantly correlated with a genetic network comprising multiple linearly coupled gene variants that explained ~4% of the ERP phenotype variance. Enrichment analysis revealed epidermal growth factor, endocannabinoid signaling, glutamatergic synapse and maltohexaose transport associated with P2 component of the N1-P2 ERP waveform. This ERP component also showed deficits in SZ and PBP.
CONCLUSIONS: Aberrant P2 component in psychosis was associated with gene networks regulating several fundamental biologic functions, either general or specific to nervous system development. The pathways and processes underlying the gene clusters play a crucial role in brain function, plausibly implicated in psychosis.
© The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  bipolar disorder; event-related potential; gene; pathway; psychosis; schizophrenia; single nucleotide polymorphism

Mesh:

Year:  2015        PMID: 26462502      PMCID: PMC4838080          DOI: 10.1093/schbul/sbv147

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  96 in total

1.  P50 suppression is not affected by attentional manipulations.

Authors:  K Jerger; C Biggins; G Fein
Journal:  Biol Psychiatry       Date:  1992-02-15       Impact factor: 13.382

Review 2.  Dopamine neuronal tracts in schizophrenia: their pharmacology and in vivo glucose metabolism.

Authors:  C A Tamminga; G H Burrows; T N Chase; L D Alphs; G K Thaker
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

3.  Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.

Authors:  C O'Dushlaine; E Kenny; E Heron; G Donohoe; M Gill; D Morris; A Corvin
Journal:  Mol Psychiatry       Date:  2010-02-16       Impact factor: 15.992

4.  P50, N100, and P200 sensory gating: relationships with behavioral inhibition, attention, and working memory.

Authors:  Marijn Lijffijt; Scott D Lane; Stacey L Meier; Nash N Boutros; Scott Burroughs; Joel L Steinberg; F Gerard Moeller; Alan C Swann
Journal:  Psychophysiology       Date:  2009-06-08       Impact factor: 4.016

5.  Neurophysiological Distinction between Schizophrenia and Schizoaffective Disorder.

Authors:  Daniel H Mathalon; Ralph E Hoffman; Todd D Watson; Ryan M Miller; Brian J Roach; Judith M Ford
Journal:  Front Hum Neurosci       Date:  2010-01-29       Impact factor: 3.169

6.  CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues.

Authors:  Damian M Kraus; Gary S Elliott; Hilary Chute; Thomas Horan; Karl H Pfenninger; Staci D Sanford; Stephen Foster; Sheila Scully; Andrew A Welcher; V Michael Holers
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

7.  Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP).

Authors:  Carol A Tamminga; Elena I Ivleva; Matcheri S Keshavan; Godfrey D Pearlson; Brett A Clementz; Bradley Witte; David W Morris; Jeffrey Bishop; Gunvant K Thaker; John A Sweeney
Journal:  Am J Psychiatry       Date:  2013-11       Impact factor: 18.112

8.  A meta-analysis of P50 studies in patients with schizophrenia and relatives: differences in methodology between research groups.

Authors:  O M de Wilde; L J Bour; P M Dingemans; J H T M Koelman; D H Linszen
Journal:  Schizophr Res       Date:  2007-06-29       Impact factor: 4.939

9.  Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia.

Authors:  Nadine Norton; Valentina Moskvina; Derek W Morris; Nicholas J Bray; Stanley Zammit; Nigel M Williams; Hywel J Williams; Anna C Preece; Sarah Dwyer; Jennifer C Wilkinson; Gillian Spurlock; George Kirov; Paul Buckland; John L Waddington; Michael Gill; Aiden P Corvin; Michael J Owen; Michael C O'Donovan
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-01-05       Impact factor: 3.568

10.  The estrogen hypothesis of schizophrenia implicates glucose metabolism: association study in three independent samples.

Authors:  Line Olsen; Thomas Hansen; Klaus D Jakobsen; Srdjan Djurovic; Ingrid Melle; Ingrid Agartz; Haakan Hall; Henrik Ullum; Sally Timm; August G Wang; Erik G Jönsson; Ole A Andreassen; Thomas Werge
Journal:  BMC Med Genet       Date:  2008-05-06       Impact factor: 2.103

View more
  3 in total

1.  Neurocognitive subtypes in patients with bipolar disorder and their unaffected siblings.

Authors:  M Russo; T E Van Rheenen; M Shanahan; K Mahon; M M Perez-Rodriguez; A Cuesta-Diaz; E Larsen; A K Malhotra; K E Burdick
Journal:  Psychol Med       Date:  2017-06-07       Impact factor: 7.723

Review 2.  Precision Psychiatry: Biomarker-Guided Tailored Therapy for Effective Treatment and Prevention in Major Depression.

Authors:  Candace Jones; Charles B Nemeroff
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Genome-wide association studies of smooth pursuit and antisaccade eye movements in psychotic disorders: findings from the B-SNIP study.

Authors:  R Lencer; L J Mills; N Alliey-Rodriguez; R Shafee; A M Lee; J L Reilly; A Sprenger; J E McDowell; S A McCarroll; M S Keshavan; G D Pearlson; C A Tamminga; B A Clementz; E S Gershon; J A Sweeney; J R Bishop
Journal:  Transl Psychiatry       Date:  2017-10-24       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.